Sensex gains 50 points, Nifty tops 11,050; Biocon drops 2% on USFDA observations07 Mar, 2019, 09.37 AM ISTNo form 483 has been issued by USFDA: Biocon18 Mar, 2014, 11.48 AM ISTWatch: Kiran Mazumdar Shaw on USFDA approval to Biocon-Mylan's biosimilar drug04 Dec, 2017, 09.13 PM ISTIndia’s first clean economy index fund is here: Should you invest?
Sensex rises over 250 points, Nifty above 23,900 as markets extend gains; HCL Tech among top gainers
Iran fight back twice to earn dramatic 2-2 draw against New Zealand in FIFA World Cup
TCS to take $70 million hit after US Supreme Court rejects appeal in trade secrets case
Shiv Sena not interested in breaking any party: Shaina NC amid "Operation Tiger" buzz
GIC shares decline 6% as Rs 3,088 crore OFS opens at 9% discount
FIFA World Cup 2026: Late equaliser from Araujo helps Uruguay play 1-1 draw against Saudi Arabia
OpenAI spending hit $34 billion last year ahead of planned IPO: Report
China Shock 2.0: Surging Chinese exports threaten Europe's economy, raising concern at G7 summit
ET Alpha Wealth Summit | FIIs haven't abandoned India, they've just reshuffled: Samir Arora
What to know about the demining and escort mission that US allies want for the Strait of Hormuz
Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service